Sandro Feriozzi (S Feriozzi)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Topics

Replacement Therapy

Hypertrophic Cardiomyopathy

Tyrosine Kinase

Top Venues

Drug design, development and therapy

Journal of clinical medicine

AJNR. American journal of neuroradiology

Journal of nephrology

This page only lists publications with an associated author ORCID identifier.

Publications

Sandro Feriozzi, Cristina Chimenti, Ricardo Claudio Reisin
Updated Evaluation of Agalsidase Alfa Enzyme Replacement Therapy for Patients with Fabry Disease: Insights from Real-World Data. Drug design, development and therapy 18 (2024)
Sandro Feriozzi, Cristina Chimenti, Ricardo Claudio Reisin
Updated Evaluation of Agalsidase Alfa Enzyme Replacement Therapy for Patients with Fabry Disease: Insights from Real-World Data. Drug design, development and therapy 18 (2024)
Markus Cybulla, Kathleen M Nicholls, Sandro Feriozzi, Aleš Linhart, Josep María Cruzado, Bojan Vujkovac, Jaco Botha, Christina Anagnostopoulou, Michael L West, null null
Renoprotective Effect of Agalsidase Alfa: A Long-Term Follow-Up of Patients with Fabry Disease. Journal of clinical medicine 11 (16) (2022)
Sandro Feriozzi, Paula Rozenfeld
Pathology and pathogenic pathways in fabry nephropathy. Clinical and experimental nephrology 25 (9) (2021)
Sandro Feriozzi, Derralynn A Hughes
New drugs for the treatment of Anderson-Fabry disease. Journal of nephrology 34 (1) (2020)
Sirio Cocozza, Camilla Russo, A Pisani, Gaia Olivo, Eleonora Riccio, Amedeo Cervo, Giuseppe Pontillo, Sandro Feriozzi, Pierfrancesco Veroux, Battaglia Yuri, Daniela Concolino, Federico Pieruzzi, Renzo Mignani, Pasquale Borrelli, Massimo Imbriaco, Arturo Brunetti, Enrico Tedeschi, Giuseppe Palma
Redefining the Pulvinar Sign in Fabry Disease. AJNR. American journal of neuroradiology 38 (12) (2017)